Xin Wei Wang

40.6k citations
359 papers · 26.9k indexed · 19 hit papers · h-index 86

Impact in

  • Cancer Research top 0.05%
    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
  • Hepatology top 0.1%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • MicroRNA in disease regulation 41
    • Cancer Genomics and Diagnostics 31
    • Cancer-related molecular mechanisms research 30
    • Hepatocellular Carcinoma Treatment and Prognosis 24

Xin Wei Wang

345 papers receiving 26.4k citations

Hit Papers

Biomarkers for immunotherapy of hepatocellular carcinoma 2023 · 109 citations
1091994202620042015250500750

Peers

Xin Wei Wang
Comparison fields: 5 of 190
  • Cancer Research 8.7k
  • Hepatology 3.9k
  • Oncology 8.0k
  • Molecular Biology 15.4k
  • Geriatrics and Gerontology 798
Replace Jian Zhou with:
Jian Zhou China
Xin‐Yuan Guan China
Hongyang Wang China
Bing‐Hua Jiang China
Kurt Zatloukal Austria
Jing‐Yuan Fang China
Qi Zhang China
Cheng Qian China
William C. Hahn United States
Joseph R. Testa United States
Xin Wei Wang relative to Jian Zhou China Jian Zhou's profile →
Citations per field
00.5×5.6×
Jian Zhou · 1×
Citations per year

Countries citing papers authored by Xin Wei Wang

Since Specialization
Citations

This map shows the geographic impact of Xin Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Wei Wang more than expected).

Fields of papers citing papers by Xin Wei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Wei Wang. The network helps show where Xin Wei Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xin Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xin Wei Wang Line = papers co-authored together Xin Wei Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20253
3 20250
4 20241
5 20241
6 20240
7 20246
8 20242
9 20232
10 20239
11 20235
12 202318
13 202021
14 2013111
15
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Hit paper breakdown →
2010757
16 201058
17 2009319
18
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
Hit paper breakdown →
2008577
19 2007169
20 200587

About Xin Wei Wang

Xin Wei Wang is a scholar working on Cancer Research, Hepatology, Oncology, Molecular Biology and Biotechnology, having authored 359 papers that have together received 26.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (41 papers), Cancer-related Molecular Pathways (39 papers), RNA modifications and cancer (34 papers), Cancer Genomics and Diagnostics (31 papers), Cancer-related molecular mechanisms research (30 papers), Hepatocellular Carcinoma Treatment and Prognosis (24 papers), DNA Repair Mechanisms (23 papers) and Hepatitis B Virus Studies (20 papers). The work is most often cited by research in Cancer Research (8.7k citations), Hepatology (3.9k citations), Oncology (8.0k citations), Molecular Biology (15.4k citations) and Geriatrics and Gerontology (798 citations). Xin Wei Wang has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Anuradha Budhu, Marshonna Forgues, Curtis C. Harris, Taro Yamashita, Junfang Ji, Qing‐Hai Ye, Hu‐Liang Jia, C C Harris, Lun–Xiu Qin and Tim F. Greten. Their work appears in journals such as Hepatology, Scientific Reports, Proceedings of the National Academy of Sciences, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026